Philip C Comp
Overview
Explore the profile of Philip C Comp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
345
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Comp P
Thromb Res
. 2003 Dec;
111(1-2):3-8.
PMID: 14644071
Venous thromboembolic (VTE) disease consists of deep vein thrombosis and/or pulmonary embolism. Either low molecular weight heparin given subcutaneously or unfractionated heparin administered intravenously are used for the initial treatment....
12.
Francis C, Berkowitz S, Comp P, Lieberman J, Ginsberg J, Paiement G, et al.
N Engl J Med
. 2003 Oct;
349(18):1703-12.
PMID: 14585938
Background: In a previous study of the prevention of venous thromboembolism after total knee replacement, the efficacy of ximelagatran, an oral direct thrombin inhibitor that does not require monitoring of...
13.
Comp P
Pharmacotherapy
. 2003 Jun;
23(6):772-87.
PMID: 12820819
Venous thromboembolism is a serious, frequent, and potentially fatal complication of major orthopedic surgery. Currently available pharmacologic agents for the prevention of venous thromboembolism in this high-risk population consist of...
14.
Rossi M, Yokota T, Medina K, Garrett K, Comp P, Schipul Jr A, et al.
Blood
. 2002 Oct;
101(2):576-84.
PMID: 12393702
This study addressed several questions concerning age-related changes in human B lymphopoiesis. The relative abundance of pro-B, pre-B, immature, naive, and mature B cells among the CD19(+) lymphocyte fraction of...
15.
Strandness Jr D, Dalman R, Panian S, Rendell M, Comp P, Zhang P, et al.
Vasc Endovascular Surg
. 2002 Apr;
36(2):83-91.
PMID: 11951094
A multicenter, double-blind, randomized, placebo-controlled, parallel study was conducted to compare the efficacy and safety of cilostazol 100 mg and 50 mg, both administered twice daily, with that of placebo...